Sanofi ends option phase of rare disease alliance with Alnylam

8th April 2019 Uncategorised 0

Through the agreement Alnylam will advance an additional investigational asset in an undisclosed rare genetic disease.

More: Sanofi ends option phase of rare disease alliance with Alnylam
Source: News